A Pilot Validation Study of Continuous CO2-based End-expiratory Lung Volume Measurements in Humans. (ELVIS)

April 10, 2018 updated by: Tomas Öhman, Karolinska Institutet

A Pilot Validation Study of Continuous CO2-based End-expiratory Lung Volume Measurements in Humans and an Experimental Porcine Model.

The capnodynamic method non-invasively calculates effective lung volume (ELV) continuously during surgery. In this study ELV is compared to functionalresidual capacity (FRC) measured with Nitrogen Multiple Breath Wash out (NMBW) at 0 and 5 cm H2O Positive End Expiratory Pressure (PEEP) in patients scheduled for neck surgery at the Karolinska University Hospital, Solna, Sweden.

Study Overview

Status

Completed

Detailed Description

The capnodynamic method continuously calculates effective lung volume (ELV) with the help of a capnodynamic equation:

ELV x (FACO2(n) - FACO2(n-1)) = delta t(n) x EPBF (CvCO2 - CvCO2(n)) - VTCO2. ELV Effective lung volume [L]. EPBF Effective pulmonary blood flow [L/min]. n current breath. n-1 previous breath. FACO2 mean alveolar carbon dioxide fraction. CvCO2 mixed venous carbon dioxide content [Lgas/Lblood]. CcCO2n pulmonary end-capillary carbon dioxide content [Lgas/Lblood]. VTCO2n volume [L] of carbon dioxide eliminated by the current, nth, breath. delta t n current breath cycle time [min]. The equation above describes the mole balance between the CO2 delivered to lungs (EPBF), the volume taking part in the gas exchange (ELV) and CO2 excreted from the lungs (VTCO2). Normally there is no difference in CO2 between the actual and the preceding breath as the same amount of CO2 as delivered to the lungs as is excreted. When small changes in CO2 concentration are inserted into the equation obtained with short inspiratory pauses in three out of nine breaths, nine different equations are obtained. The three unknown variables; ELV, EPBF and CvCO2 can be solved with a linear least square optimization, a well-known numerical mathematical principle. The breathing pattern is automatically controlled by the ventilator which provides continuous calculations of ELV where each value represents the average of the preceding nine breaths and renews with each breath as the newest replaces the oldest in the equation system.

At the day of surgery, included patients arrive at the surgical unit. After safe surgical checklist, vital signs are measured patients are anesthetized and muscle relaxed per routine practice. An endotracheal tube is inserted in the trachea and the patient connected to a ventilator. Anesthesia is maintained with Propofol in target controlled infusion and a short acting opioid is added as needed.

The protocol comprises a measurement of functional residual capacity (FRC) with the reference method, nitrogen multiple breath wash out (NMBW), at 0 cm H2O Positive End Expiratory Pressure (PEEP). The tracheal tube is then connected to the Servo-i ventilator with the capnodynamic breathing pattern applied. An ELV measurement at PEEP 0 cm H2O is followed by a measurement of ELV at PEEP 10 cm H2O and lastly a measurement of ELV at PEEP 5 cm H2O before the tube is clamped and connected to the NMBW reference method ventilator again for a measurement of FRC at PEEP 5 cm H2O.

The attending anesthesiologist has the final responsibility of the patient and could at any time end the protocol if needed.

Study Type

Observational

Enrollment (Actual)

23

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Stockholm
      • Solna, Stockholm, Sweden, SE-171 76
        • Department of Perioperative Medicine and Intensive Care, Karolinska University Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Individuals scheduled for neck surgery at Karolinska university hospital

Description

Inclusion Criteria:

  • Individuals without current heart or lung disease

Exclusion Criteria:

  • Obesitas
  • Heart disease
  • Lung disease
  • Current smoker

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Effective lung volume
Time Frame: Continous measurements during general anaesthesia and mechanical ventialtion, 45 minutes-2 hours
Lung volume measurements during mechanical ventilation based on CO2 dynamics and a differentiated Fick's principle.
Continous measurements during general anaesthesia and mechanical ventialtion, 45 minutes-2 hours

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Håkan Björne, PhD, Karolinska Institutet

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

December 1, 2014

Primary Completion (Actual)

October 21, 2015

Study Completion (Actual)

October 21, 2015

Study Registration Dates

First Submitted

April 10, 2018

First Submitted That Met QC Criteria

April 10, 2018

First Posted (Actual)

April 18, 2018

Study Record Updates

Last Update Posted (Actual)

April 18, 2018

Last Update Submitted That Met QC Criteria

April 10, 2018

Last Verified

April 1, 2018

More Information

Terms related to this study

Other Study ID Numbers

  • 2014/1393-31/2

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Pulmonary Function

Subscribe